Julie Brahmer, MD of Johns Hopkins Kimmel Comprehensive Cancer Center explains the impact of her clinical trial on current clinicians and future research. She argues how this trial is the first trial to show a five-year survival rate for non-small cell lung cancer. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
First Trial Showing a Five-Year Follow-Up in Patients with NSCLC
